Cookies and the protection of your data

We use cookies to improve the functionality of the website, to offer you a better website experience and to provide social media features. You give your consent by clicking on “Accept all Cookies” or as part of your individual settings. Please find detailed information on the use of cookies on this website in our Data Privacy Statement.

Functional Cookies

These cookies are necessary for the operation of the site and enable security-relevant functions. In addition, we determine whether you want to remain logged in and to make our services available to you when you change between this and other websites.

Statistical Cookies

These cookies are used for analyzing user behavior on our website with the aim of improving user navigation. All data collected is evaluated anonymously. Further information is available on our data protection site.

Marketing Cookies

These cookies are used to deliver relevant advertising or to limit how many times you see an ad. Marketing cookies can share that information with the advertiser (third-party cookies). The legal basis for the data processing is the consent of the user.

ObeEnd Weight Loss Wristband
ObeEnd Weight Loss Wristband
ObeEnd Weight Loss Wristband
ObeEnd Weight Loss Wristband
ObeEnd Weight Loss Wristband
ObeEnd Weight Loss Wristband
ObeEnd Weight Loss Wristband
ObeEnd Weight Loss Wristband
ObeEnd Weight Loss Wristband
ObeEnd Weight Loss Wristband
ObeEnd Weight Loss Wristband
ObeEnd Weight Loss Wristband
ObeEnd Weight Loss Wristband
ObeEnd Weight Loss Wristband
2021

Share:

ObeEnd Weight Loss Wristband

Smart health bracelet

This is the world's first smart wearable device that integrates innovative TENS technology. ObeEnd uses an electrophysical approach to help users control caloric intake, avoiding any chemical side effects. ObeEnd uses targeted neuromodulation technology, providing precise electric stimulating of acupuncture point PC6 to control body weight. ObeEnd generates targeted electric stimulation to PC6, which helps reduce hunger and appetite by reducing gastric secretion signals from the brain. ObeEnd’s efficacy is supported by numerous scientific studies from across the world.

Client / Manufacturer

WAT Medical Enterprise Ltd.

Vancouver, BC, CA
Design
CH-LAB Design Studio

CH-LAB Design Studio

Ningbo, CN
Date of Launch
2021
Development Time
up to 12 months
Target Regions
Africa, Asia, Australia / Oceania, Europe, North America, South America
Target Groups
Consumer / User, Trade / Industry, Public Sector Government

RELATED PROJECTS